Case Reports Open access

Tamoxifen treatment and pulmunary embolism: a case report and literature review

Authors

Published
25 November 2015
Section
Case Reports

Abstract

Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.